Table 4.
Group (n = patients where information on follow-up was available) | Resolution of IDA |
No Resolution |
||
---|---|---|---|---|
Active treatment | Conservative management only | Active treatment | Conservative management only | |
Neoplastic pathology (n = 10) | 7: all surgical management | – | 2: further enteroscopy (1 for retrieval of retained capsule, 1 for biopsy) 1: surgical resection | – |
Non-neoplastic but significant pathology (n = 57) | 14: treatment for CD 10: further enteroscopy 4: repeat ileocolonoscopy 2: repeat CE 1: repeat UGIE 5: surgical management | 13 | 9: further SB evaluation with deep enteroscopy | 5 |
No significant pathology (n = 135) | 2: repeat ileocolonoscopy 1: Meckel’s scan | 82 | 2: further SB evaluation 1: repeat CE 1: repeat UGIE and ileocolonoscopy | 45 |
CD: Crohn’s disease; CE: capsule endoscopy; SB: small bowel; UGIE: upper gastrointestinal endoscopy
Supplementary material. Variable selection from all predictive factors analysed.